March 29, 2011 (Washington, DC) — A retrospective case series study of 7 consecutive patients with central pain associated with multiple sclerosis (MS) has demonstrated that ziconotide (Prialt, Azur ...

Jan. 6, 2004 — Ziconotide is effective in treating pain from cancer or AIDS, according to the results of a double-blind, randomized controlled trial published in the Jan. 7 issue of The Journal of the ...

The active agent ziconotide, the synthetic toxin of the cone snail, was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing ...

Analysis of resilience scores in a cohort of solid tumors ambulatory cancer patients in chemotherapy treatment This is an ASCO Meeting Abstract from the 2009 ASCO Annual Meeting I. This abstract does ...

DEERFIELD, Ill., July 18, 2025--(BUSINESS WIRE)--TerSera Therapeutics LLC, a biopharmaceutical company with a focus in oncology, rare disease, and non-opioid pain management, announced today that its ...

Characterization of cancer pain syndromes (PS) seen at a Comprehensive Cancer Center (CCC) and pain response (PR) to palliative care consultation (PCC) This is an ASCO Meeting Abstract from the 2006 ...

The patient demonstrated two neuropathic pain syndromes, namely at- and below-level pain. These syndromes were recalcitrant to conservative measures and a decision was made to proceed with intrathecal ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Ziconotide (CAS 107452-89-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...

This release is available in German. The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago ...